Comprehensive analysis of 2024-2025 reports exposes how persistent poverty and geographic isolation are widening the gap in cancer outcomes globally.
IndiaNIC
Researchers at MUSC Hollings Cancer Center have developed an antibody targeting the SFRP2 protein, opening a new front in the battle against triple-negative breast cancer.
IndiaNIC
Comprehensive analysis of 2024-2025 reports exposes how persistent poverty and geographic isolation are widening the gap in cancer outcomes globally.
IndiaNIC · 16 Dec 2025 · 4 min read
Researchers at MUSC Hollings Cancer Center have developed an antibody targeting the SFRP2 protein, opening a new front in the battle against triple-negative breast cancer.
IndiaNIC · 15 Dec 2025 · 4 min read
Comprehensive analysis of 2024-2025 reports exposes how persistent poverty and geographic isolation are widening the gap in cancer outcomes globally.
IndiaNIC · 16 Dec 2025
IndiaNIC · 15 Dec 2025
Popular topics
ESC to close · ⌘K to open
We use essential cookies to run the site and optional ones to understand what gets read.
Cookie settings
Granular control, stored on this device and honoured on every page.